Skip to content
Screener

Total debt at other companies

Abbott logo
AbbottABT
$32.61B+143%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$49.04B-3.4%
AtriCure logo
AtriCureATRC
$75.47M-3.8%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$821.56M+0.5%
AngioDynamics logo
AngioDynamicsANGO
$10.96M+8.0%
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$434.0K
Gross profit$161.0K
Operating income-$25.3M-24.6%
Net income-$24.7M-28.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$101.6M-4.4%
Total equity$99.5M-4.8%
Total assets$115.6M-3.9%

Cash flow

See full
Operating cash flow-$18.7M-46.1%
CapEx$90.0K-12.6%
Free cash flow-$18.8M-45.6%

Valuation

See full
Market cap$2.65B+156%
Enterprise value$2.55B+173%
P/S2,233.4×

Profitability

See full
Gross margin-0.1%
Operating margin-7,007.8%
Net margin-6,755.8%
FCF margin-5,180.4%

Returns & leverage

See full
Return on equity-78.5%-15.3pp
Debt / equity0.1×0.0×
Current ratio9.6×-2.4×

Where this comes from

Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $6.77M.

The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:23 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001437749-26-026288

FAQ

What is Pulse Biosciences, Inc.'s total debt?
Pulse Biosciences, Inc. (PLSE) reported total debt of $6.77M in Q2 2026.
How has Pulse Biosciences, Inc.'s total debt changed year-over-year?
Pulse Biosciences, Inc.'s total debt decreased by 17.9% year-over-year, from $8.25M to $6.77M.
What is the long-term trend for Pulse Biosciences, Inc.'s total debt?
Over 5 years (2020 to 2025), Pulse Biosciences, Inc.'s total debt has grown at a -7.9% compound annual growth rate (CAGR), from $11.36M to $7.53M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.

Ask your AI about Pulse Biosciences, Inc.'s total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude